MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Effects of Exogenous Melatonin on Sleep and Motor Symptoms in Parkinson’s Disease: A Systematic Review and Meta-Analysis

    M. Alghaniem, A. Abunamoos, F. Qtaishat, A. Rababah, M. Abu Hasna, Y. Aljazi, M. Mustafa, F. Alnajjar, T. Patel, N. Hamam (Amman, 11942, Jordan)

    Objective: To evaluate melatonin's efficacy in enhancing sleep and motor symptoms in Parkinson’s disease (PD) through an updated systematic review and meta-analysis. Background: Sleep disturbances…
  • 2025 International Congress

    The sphingolipid Lyso-Gb3, a biomarker for the lysosomal storage disorder Fabry Disease, is significantly elevated in blood from patients with Parkinson’s Disease

    C. Beetz, C. Cozma, M. Iurascu, S. Fischer, S. Oppermann, K. Kandaswamy, P. Bauer (Rostock, Germany)

    Objective: To better understand lysosomal dysfunction in Parkinson’s Disease. Background: Lysosomal dysfunction and α-synuclein accumulation play central roles in Parkinson’s Disease. They are interconnected by…
  • 2025 International Congress

    Evaluation of the Pharmacodynamic Effects of BIIB122/DNL151 in Participants with LRRK2 mutation-driven Parkinson’s disease (BEACON Study)

    J. Kluss, S. Huntwork-Rodriguez, D. Jennings, S. Ota, R. Maciuca, J. Alkabsh, S. Davis, J. Suh, M. Schwarzschild, K. Fraser, R. Llorens-Arenas, C. Ho, P. Chin (South San Francisco, USA)

    Objective: To characterize the biomarker effects of BIIB122/DNL151 in participants with LRRK2 pathogenic mutations diagnosed with Parkinson’s disease (LRRK2-PD). Background: BIIB122/DNL151 is a CNS-penetrant small…
  • 2025 International Congress

    Utilization of Phosphorylated Alpha-Synuclein Skin Biopsy Testing in a Movement Disorders Center

    S. Anis, A. Kundrick, C. Piccinin, T. Lopez-Gonzalez, D. Dos Santos, H. Fernandez (Cleveland, USA)

    Objective: To describe the utilization patterns of skin biopsy for phosphorylated alpha-synuclein (P-syn) aggregation obtained from three sites (posterior cervical, distal thigh, distal leg) and…
  • 2025 International Congress

    Parkinson’s Disease and Type 2 Diabetes Severity: a Case-control Biomarker Study

    B. Huxford, A. Zirra, E. Camboe, K. Dey, D. Gallagher, C. Budu, C. Simonet, T. Boyle, R. Dobson, A. Noyce (London, United Kingdom)

    Objective: We used blood-based markers of neuroaxonal damage, inflammation, and glycaemic control to examine whether Type 2 Diabetes (T2D) is linked to a more severe…
  • 2025 International Congress

    Broad spectrum local field potential activities as a novel biomarker for adaptive deep brain stimulation

    CH. Tai, YC. Lin, WH. Hu, MT. Hsu, SH. Tseng (Hsinchu, Taiwan)

    Objective: This study aims to evaluate the wider frequency range (1-200 Hz) LFPs as the novel neural biomarkers for adaptive DBS. In parkinsonism rats, we…
  • 2025 International Congress

    Enhancing Parkinson’s Disease Detection Through Chemical and Motor Biomarkers

    C. Marshall, M. Kling, L. Linch, N. Hashemi, E. Stegemoller (Ames, USA)

    Objective: To assess the relationship between gait performance and the noninvasive detection of gaseous biomarkers emitted from the skin in denovo persons with Parkinson's disease…
  • 2025 International Congress

    Validation of CSF Alpha-synuclein SAA in an Autopsy Cohort with Systemic Assessment of Lewy Pathology Including the Body

    M. Kurihara, T. Matsubara, K. Satoh, A. Arakawa, M. Hara, K. Kanemaru, A. Iwata, S. Murayama, Y. Saito (Tokyo, Japan)

    Objective: Based on the recent recommendations by international neuropathologists [1], we attempted to evaluate the diagnostic accuracy of cerebrospinal fluid (CSF) alpha-synuclein (α-syn) seeding amplification…
  • 2025 International Congress

    Interactions between APOE E4 and idiopathic Parkinson’s disease in age-related hearing loss

    M. Kmiecik, M. Mcintyre, B. Nguyen, A. Guan, M. Holmes, S. Aslibekyan (Sunnyvale, USA)

    Objective: Examine the interaction between APOE E4 and idiopathic Parkinson’s disease (PD) on age-related hearing loss using a validated web-based speech-in-noise assessment. Background: Age is…
  • 2025 International Congress

    Aberrations in Voluntary Thought Initiation: Parallels to Motor Freezing in Basal Ganglia Dysfunction

    S. Shugar, N. Choudhury, D. Nolasco, B. Carr (Gainesvile, USA)

    Objective: To explore the neurophysiological basis of impaired volitional thought initiation focusing on dorsal caudate dysfunction, aberrant pallidal-thalamic inhibition, and impaired corticostriatal integration. Background: While…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley